RESULTS:
10. Did any patients deny participation or were excluded from other reasons from the telephone interview? In that case, how many? 11. The majority of the patients had poor compliance. What was the proportion of patients with poor and good compliance among patients who had newly diagnosed hypertension or not? It is written in the "Discussion" that the statistical analyses were controlled for, for instance compliance. How was that performed in relation to the cut-off of AHI<15 with MAD as a criterion for the risk for newly diagnosed hypertension during treatment? DISCUSSION: 12.Why do the authors think that only AHI<15 and none of the other success criteria predicted the development of hypertension during treatment? REFERENCES: 13. Some of the references that state a relationship between OSA and hypertension are very old. A new large one should be included, Mokhlesi et 
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GENERAL COMMENTS
The authors investigated the success criteria of MAD based on longterm symptoms and new-onset hypertension. It is very novelty and clinically useful to focus the long-term symptoms and new-onset hypertension instead of short-term residual AHI. I have some concerns about this manuscript, as below.
1.
Page 7; about PSG and Watch PAT Authors described "patients underwent PSG or Watch PAT twice; before and 3 months after the application of MAD". In terms of each patient, did the same device was underwent for before and 3 months the assessment? It is better to present the limitation of reliability of using Watch PAT.
2.
Page 10; about follow-up duration It may be kind for readers to describe about the follow-up duration in Long-term Symptomatic Changes (P10, L22). Authors presented that in Table 2 , but it's not enough.
3.
Page 11; about other potential factors for new-onset hypertension.
Authors presented only the post treatment AHI as the factor for newonset hypertension. I guess that pre treatment AHI and BMI may be also potential factors for new-onset hypertension. It is better to show the significance of the post treatment AHI (AHI<15) as the factor for new-onset hypertension compare the other potential factors.
4.
Page 13; about the adjusted analysis
Authors described "we adjusted the effects for the age, sex, body mass index, and compliance in the statistical analyses". Where dose this result described in detail?
VERSION 1 -AUTHOR RESPONSE

Responses to editor's and reviewers' comments ---------------------------------------------------------------------------------Editor
Please include the study design and setting in the title. This is the preferred format of the journal. section. "Patients were not involved in setting the research question and in the design of the study. We introduced the purpose of this research to the patients. Informed consents were sought from all the participants. All the participants completed this survey on the voluntary basis. Small gifts were given to the participants who completed this telephonic interview. No patient was asked for advice on interpretation or writing up of results. The results of the research will not be disseminated to the patients."
In addition, we added statement for thank to patient advisers in the acknowledgement. "Acknowledgements: We would like to thank all members of research team for the patient advisers and for the assistance in data collection."
The There are, however, some questions about the methodology, results and references. INTRODUCTION: Page 6 1. Line 13: Add the word "CPAP" and delete the word "the" before in the sentence: "A short-term randomized controlled trial showed that CPAP the treatment for OSA reduces cardiovascular morbidity".
the word "the" in that sentence. 6. What type of MAD was used? e used customized monobloc MAD which was fabricated at our sleep clinic to hold the mandible fixed at 60% of the maximum protrusion.
7. Was blood pressure objectively measured at the start of mandibular advancement device therapy? How was it otherwise possible to know that the patients developed hypertension during treatment? medical diseases including hypertension and current medications had also been collected. The information about the occurrence of physician-diagnosed new-onset hypertension was collected via a longitudinal review of our electronic medical system and telephonic interviews about anti-hypertensive medications and physician-diagnosed hypertension. . 8. Were the questions sent to the patients before the telephone interview in order for them to prepare for the answers? How was it otherwise possible to know that the answers were correct?
, but, instead, we telephoned at least twice for each patient with the same questionnaires to confirm their answers. (We added this in the section of Methods -Collection of Follow-up Data) Although all the patients answered the questions without difficulty, the telephone interview-based study design having a potential of interviewer bias and respondent's recall bias is still a limitation of our study.
Page 7 9. Lines 36-38: "The MAD was designed to hold the mandible fixed at 60% of the maximum protrusion without an open bite." Comment: Please describe better what the authors mean by the last 3 words.
-incisal distance. We think that those words are not necessary, and so we would like to delete four words, "without an open bite".
RESULTS:
10. Did any patients deny participation or were excluded from other reasons from the telephone interview? In that case, how many?
-treated patients who underwent the followup sleep study, 107 were not available for telephone interviews because of phone number change or rejection. Thus, a total of 97 patients were enrolled. We made a correction in the corresponding section of Results.
11. The majority of the patients had poor compliance. What was the proportion of patients with poor and good compliance among patients who had newly diagnosed hypertension or not? It is written in the "Discussion" that the statistical analyses were controlled for, for instance compliance. How was that performed in relation to the cut-off of AHI<15 with MAD as a criterion for the risk for newly diagnosed hypertension during treatment? f 7 patients who were newly diagnosed with hypertension had poor compliance (we added this in the section of Results) and we adjusted the compliance in the statistical analyses. Kaplan-Meier survival analyses were performed for all the 7 success criteria, only the criterion 2 (AHI < 15/h with MAD) showed a significant difference between success and failure on the basis of newonset hypertension. The corresponding part was revised as follows: "Among the 97 patients, 34 (35.1%) had hypertension before treatment and 7 patients were newly diagnosed with hypertension during the follow-up and all of the 7 patients showed poor compliance. Kaplan-Meier survival analyses were performed for all the 7 success criteria and the analysis showed that only criterion 2 (AHI < 15/h with MAD) could significantly differentiate between success and failure on the basis of new-onset hypertension (P = 0.045) (Fig. 1)". 
DISCUSSION:
12. Why do the authors think that only AHI<15 and none of the other success criteria predicted the development of hypertension during treatment? success from failure with MAD treatment based on long-term symptom improvement and occurrence of new-onset hypertension in OSA. Only AHI < 15/h with MAD predicted the new-onset hypertension and the ROC curve analysis indicated that the cutoff AHI was 16.8/h (close to 15/h), differentiating patients with new-onset hypertension from the others. As the reviewer already knows, AHI of 15 is the cutoff value differentiating moderate OSA from mild OSA. So, we may be reasoning that moderate OSA might also be a risk factor for development of hypertension supporting a more active intervention for moderate OSA. However, we still need a prospective study to validate this finding in the future. 
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